About Evexia Lifecare Limited
Data last updated:
Evexia Lifecare Limited is a public limited company based in Vadodara, Gujarat, India. It operates in the agricultural products distribution segment of the agriculture sector. It was incorporated on 23 November 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L23100GJ1990PLC014692. Its GSTIN is 24AAACJ4907C1Z3 (Gujarat). The company holds 5 GST registrations, of which 4 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 524444.
The company has an authorised share capital of ₹387 Cr and a paid-up capital of ₹187.73 Cr. It was formerly known as Kavit Industries Limited and Atreya Petrochem Limited. It is led by directors including Jayeshkumar Raichandbhai Thakkar (Managing Director) and Hasmukhbhai Dhanjibhai Thakkar.
Its last annual general meeting (AGM) was held on 30 November 2024, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Vill : Tundao Tal: Salvi, Vadodara, Gujarat, India – 391775.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹110.28 Cr. For the same year it recorded a net profit of ₹1.62 Cr (net margin 1.5%) and EBITDA of ₹2.87 Cr (EBITDA margin 2.6%). The net worth stands at ₹460.34 Cr. Total assets are valued at ₹841.67 Cr.
The company has about 14 employees on its provident fund (EPFO) records. Its group structure includes 4 subsidiaries.
The company is associated with 1 brand: Evexia Lifecare. Court records list 19 cases involving the company, including 9 filed by the company and 10 filed against it; 9 cases are pending. The company has 41 deals on record (40 market trades, 1 funding round), with disclosed funding of ₹24 Cr; the latest was in September 2026. Its 3 peer companies in the Agriculture industry (Agro Retail and Distribution, Chemical Retail and Distribution, Edible Oils), with the same principal business activity (wholesale trading) are compared by revenue, 1 larger and 2 smaller; the largest is Brijmohan Azad Singh Marketing Private Limited with revenue of ₹57.2 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website evexialifecare.com.
Company details
Name history
Evexia Lifecare has undergone 5 name changes throughout its history. The current legal name is Evexia Lifecare Limited.
| Company Name | Status |
|---|---|
| Evexia Lifecare Limited | Current |
| Kavit Industries Limited | Previous |
| Atreya Petrochem Limited | Previous |
| Jal Hi-Power Petrochem Private Limited | Previous |
| Jal Hi-Power Petrochem Limited | Previous |
CIN history
Evexia Lifecare has one previous CIN (Corporate Identification Number): U23100GJ1990PLC014692. The current CIN is L23100GJ1990PLC014692, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L23100GJ1990PLC014692 | Current |
| U23100GJ1990PLC014692 | Previous |
Contact details
Evexia Lifecare Limited's registered office is in Vadodara, Gujarat. Its website is evexialifecare.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressVill : Tundao Tal: Salvi, Vadodara, Gujarat, India – 391775
- IndustryAgriculture, Agro Retail & Distribution
To see the full contact details of Evexia Lifecare Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Evexia Lifecare operates one associated brand: Evexia Lifecare. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Contract manufacturer of pharma chemicals | evexialifecare.com |
Business activity
The main business activity of Evexia Lifecare is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Evexia Lifecare Limited, buy the company report.
Financials of Evexia Lifecare Limited
FY 2025-26 filings availableEvexia Lifecare Limited reported revenue of ₹110.28 Cr for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 110 | 56.27 | 69.55 | 75.51 | 107 | 100 | 105 |
| Revenue growth | - | -19.1% | -7.9% | -29.2% | +6.4% | -5.0% | - |
| EBITDA | 2.87 | 1.95 | 0.58 | 2.40 | (72.23) | (6.30) | (0.90) |
| EBITDA margin | +2.6% | +3.5% | +0.8% | +3.2% | -67.7% | -6.3% | -0.9% |
| Profit before tax | 2.20 | 1.92 | 1.53 | 2.16 | 1.92 | 4.90 | 2.24 |
| Net profit | 1.62 | 1.37 | 0.67 | 0.85 | 1.31 | 3.47 | 1.57 |
| Net profit margin | +1.5% | +2.4% | +1.0% | +1.1% | +1.2% | +3.5% | +1.5% |
| EPS (₹) | 0.01 | 0.02 | 0.01 | 0.03 | 0.21 | 0.56 | 0.25 |
| Balance sheet | |||||||
| Total assets | 842 | 849 | 810 | 101 | 96.44 | 169 | 176 |
| Net worth | 460 | 129 | 90.49 | 80.45 | 79.60 | 78.34 | 74.84 |
| Total debt | 382 | 686 | 705 | 5.79 | 6.78 | 7.12 | 4.12 |
| Cash & bank | 2.38 | 0.75 | 0.48 | 1.54 | 0.51 | 0.46 | 0.91 |
| Net working capital | 39.34 | 63.17 | 48.91 | 43.59 | 63.36 | 73.62 | 39.55 |
| Cash flow | |||||||
| Cash from operations | (23.48) | 17.02 | (3.15) | (5.74) | 1.71 | (2.58) | (0.26) |
| Cash from investing | 52.68 | (17.31) | (697) | 7.72 | (2.43) | 0.54 | 0.02 |
| Cash from financing | (27.66) | 0.56 | 699 | (0.95) | 0.77 | 1.59 | 0.42 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 25.02 | 30.89 | 36.79 | 25.24 | 25.73 | 22.09 | 23.61 | 21.70 |
| Revenue growth (YoY) | -2.8% | +39.8% | +55.8% | +16.3% | -3.7% | +4.1% | - | - |
| Other income | 0.80 | 0.15 | 0.10 | 0.26 | 0.43 | 0.00 | 0.00 | 0.10 |
| EBITDA | (0.07) | 0.53 | 1.11 | 0.25 | 0.11 | 1.07 | 1.31 | 0.17 |
| EBITDA margin | -0.3% | +1.7% | +3.0% | +1.0% | +0.4% | +4.8% | +5.5% | +0.8% |
| Depreciation | 0.29 | 0.11 | 0.30 | 0.12 | 0.03 | 0.21 | 0.46 | 0.11 |
| Interest | 0.07 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.41 | 0.00 |
| Profit before tax | 0.37 | 0.56 | 0.91 | 0.39 | 0.51 | 0.85 | 0.44 | 0.16 |
| Tax | 0.13 | 0.15 | 0.12 | 0.10 | 0.14 | 0.22 | 0.14 | 0.04 |
| Net profit | 0.24 | 0.41 | 0.79 | 0.29 | 0.37 | 0.63 | 0.30 | 0.12 |
| EPS (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 105 | 83.89 | 54.90 | 68.73 | 71.63 | 50.68 | 97.42 |
| Revenue growth | +25.7% | +52.8% | -20.1% | -4.1% | +41.3% | -48.0% | - |
| EBITDA | 1.83 | 1.95 | 1.56 | 1.56 | 2.35 | (72.29) | (5.98) |
| EBITDA margin | +1.7% | +2.3% | +2.8% | +2.3% | +3.3% | -142.6% | -6.1% |
| Profit before tax | 2.05 | 1.21 | 1.52 | 2.85 | 2.08 | 1.86 | 4.91 |
| Net profit | 1.52 | 0.73 | 1.16 | 1.99 | 0.80 | 1.29 | 3.49 |
| Net profit margin | +1.4% | +0.9% | +2.1% | +2.9% | +1.1% | +2.6% | +3.6% |
| EPS (₹) | 0.01 | 0.00 | 0.02 | 0.03 | 0.03 | 0.20 | 0.56 |
| Balance sheet | |||||||
| Total assets | 812 | 809 | 788 | 800 | 101 | 96.24 | 168 |
| Net worth | 436 | 435 | 105 | 91.35 | 80.35 | 79.52 | 78.29 |
| Total debt | 376 | 374 | 683 | 695 | 5.65 | 6.70 | 5.83 |
| Cash & bank | 0.09 | 0.03 | 0.39 | 0.07 | 1.13 | 0.36 | 0.22 |
| Net working capital | 38.66 | 39.14 | 32.48 | 46.10 | 43.29 | 63.15 | 72.20 |
| Cash flow | |||||||
| Cash from operations | (22.88) | (5.93) | (2.18) | (2.53) | (4.88) | 3.96 | (1.67) |
| Cash from investing | 21.92 | (14.51) | 2.22 | (697) | 5.68 | (4.71) | 1.92 |
| Cash from financing | 1.02 | 20.08 | 0.27 | 699 | (0.03) | 0.88 | (0.37) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 23.83 | 29.66 | 35.18 | 24.60 | 25.03 | 20.66 | 15.18 | 21.58 |
| Revenue growth (YoY) | -4.8% | +43.6% | +131.8% | +14.0% | -6.3% | +1.2% | - | - |
| Other income | 0.80 | 0.02 | 0.55 | 0.26 | 0.34 | 0.00 | 0.03 | 0.10 |
| Total expenses | 23.92 | 29.01 | 34.85 | 24.19 | 24.82 | 19.74 | 15.10 | 21.31 |
| EBITDA | (0.09) | 0.65 | 0.33 | 0.41 | 0.21 | 0.92 | 0.08 | 0.27 |
| EBITDA margin | -0.4% | +2.2% | +0.9% | +1.7% | +0.8% | +4.5% | +0.5% | +1.3% |
| Depreciation | 0.19 | 0.11 | 0.31 | 0.12 | 0.12 | 0.12 | 0.16 | 0.11 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.31 | 0.00 |
| Profit before tax | 0.52 | 0.56 | 0.57 | 0.55 | 0.43 | 0.79 | (0.36) | 0.26 |
| Tax | 0.13 | 0.15 | 0.10 | 0.14 | 0.11 | 0.21 | 0.14 | 0.07 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 25.02 | 30.89 | 36.79 | 25.24 | 25.73 | 22.09 | 23.61 | 21.70 |
| Revenue growth (YoY) | -2.8% | +39.8% | +55.8% | +16.3% | -3.7% | +4.1% | - | - |
| Other income | 0.80 | 0.15 | 0.10 | 0.26 | 0.43 | 0.00 | 0.00 | 0.10 |
| EBITDA | (0.07) | 0.53 | 1.11 | 0.25 | 0.11 | 1.07 | 1.31 | 0.17 |
| EBITDA margin | -0.3% | +1.7% | +3.0% | +1.0% | +0.4% | +4.8% | +5.5% | +0.8% |
| Depreciation | 0.29 | 0.11 | 0.30 | 0.12 | 0.03 | 0.21 | 0.46 | 0.11 |
| Interest | 0.07 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.41 | 0.00 |
| Profit before tax | 0.37 | 0.56 | 0.91 | 0.39 | 0.51 | 0.85 | 0.44 | 0.16 |
| Tax | 0.13 | 0.15 | 0.12 | 0.10 | 0.14 | 0.22 | 0.14 | 0.04 |
| Net profit | 0.24 | 0.41 | 0.79 | 0.29 | 0.37 | 0.63 | 0.30 | 0.12 |
| EPS (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | FY 2025-26 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|---|---|
| Revenue | 110 | 56.27 | 69.55 | 75.51 | 107 | 100 | 105 |
| Revenue growth | - | -19.1% | -7.9% | -29.2% | +6.4% | -5.0% | - |
| Other income | 0.00 | 0.88 | 1.88 | 0.07 | 74.40 | 11.72 | 3.48 |
| Total expenses | 107 | 54.32 | 68.97 | 73.11 | 179 | 106 | 106 |
| Employee cost | 0.00 | 0.55 | 0.78 | 0.15 | 0.22 | 0.25 | 0.48 |
| EBITDA | 2.87 | 1.95 | 0.58 | 2.40 | (72.23) | (6.30) | (0.90) |
| EBITDA margin | +2.6% | +3.5% | +0.8% | +3.2% | -67.7% | -6.3% | -0.9% |
| Depreciation | 0.66 | 0.42 | 0.39 | 0.21 | 0.24 | 0.31 | 0.32 |
| Interest | 0.01 | 0.49 | 0.54 | 0.10 | 0.01 | 0.21 | 0.02 |
| Profit before tax | 2.20 | 1.92 | 1.53 | 2.16 | 1.92 | 4.90 | 2.24 |
| Tax | 0.58 | 0.55 | 0.86 | 1.31 | 0.64 | 1.43 | 0.68 |
| Net profit | 1.62 | 1.37 | 0.67 | 0.85 | 1.31 | 3.47 | 1.57 |
| Net profit margin | +1.5% | +2.4% | +1.0% | +1.1% | +1.2% | +3.5% | +1.5% |
| EPS (₹) | 0.01 | 0.02 | 0.01 | 0.03 | 0.21 | 0.56 | 0.25 |
| Particulars | FY 2025-26 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 188 | 70.80 | 66.44 | 61.93 | 61.93 | 61.93 | 61.93 |
| Reserves & surplus | 251 | 58.59 | 24.05 | 18.52 | 17.67 | 16.41 | 12.91 |
| Shareholders' funds (net worth) | 460 | 129 | 90.49 | 80.45 | 79.60 | 78.34 | 74.84 |
| Minority interest | (0.47) | (0.03) | (0.18) | 0.06 | 0.05 | 0.03 | 0.03 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 382 | 686 | 705 | 5.79 | 6.78 | 7.12 | 4.12 |
| Total debt | 382 | 686 | 705 | 5.79 | 6.78 | 7.12 | 4.12 |
| Total liabilities | 842 | 849 | 810 | 101 | 96.44 | 169 | 176 |
| Assets | |||||||
| Gross block | 17.53 | 14.93 | 14.77 | 12.36 | 12.01 | 11.89 | 9.19 |
| Net block | 11.99 | 10.72 | 10.98 | 8.96 | 8.84 | 8.94 | 8.62 |
| Capital work in progress | 6.01 | 0.03 | 0.03 | 2.16 | 0.00 | 0.00 | 0.00 |
| Investments | 731 | 724 | 704 | 0.87 | 0.87 | 0.01 | 0.01 |
| Inventories | 2.57 | 1.11 | 2.01 | 1.35 | 3.30 | 0.61 | 0.85 |
| Sundry debtors | 85.45 | 43.54 | 31.34 | 15.16 | 45.68 | 68.29 | 57.02 |
| Cash & bank balances | 2.38 | 0.75 | 0.48 | 1.54 | 0.51 | 0.46 | 0.91 |
| Loans & advances | 14.20 | 51.70 | 52.75 | 51.64 | 59.60 | 59.33 | 28.87 |
| Total current assets | 105 | 97.10 | 86.58 | 69.69 | 109 | 129 | 87.65 |
| Total current liabilities | 65.26 | 33.93 | 37.67 | 26.10 | 45.73 | 55.07 | 48.10 |
| Net working capital | 39.34 | 63.17 | 48.91 | 43.59 | 63.36 | 73.62 | 39.55 |
| Total assets | 842 | 849 | 810 | 101 | 96.44 | 169 | 176 |
| Particulars | FY 2025-26 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.84 | 0.48 | 1.54 | 0.51 | 0.46 | 0.91 | 0.74 |
| Net cash from operating activities | (23.48) | 17.02 | (3.15) | (5.74) | 1.71 | (2.58) | (0.26) |
| Net cash from investing activities | 52.68 | (17.31) | (697) | 7.72 | (2.43) | 0.54 | 0.02 |
| Net cash from financing activities | (27.66) | 0.56 | 699 | (0.95) | 0.77 | 1.59 | 0.42 |
| Net change in cash | 1.53 | 0.28 | (1.07) | 1.03 | 0.05 | (0.46) | 0.17 |
| Closing cash | 2.38 | 0.75 | 0.48 | 1.54 | 0.51 | 0.46 | 0.91 |
| Particulars | FY 2025-26 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | - | -19.1% | -7.9% | -29.2% | +6.4% | -5.0% | - |
| EBITDA growth | - | +236.2% | -75.8% | +103.3% | -1046.5% | -600.0% | - |
| PBT growth | +14.6% | +25.5% | -29.2% | +12.5% | -60.8% | +118.8% | +211.1% |
| Net income growth | - | +104.5% | -21.2% | -35.1% | -62.3% | +121.0% | - |
| Revenue CAGR (3Y) | +13.5% | -19.2% | -11.5% | -10.5% | +12.9% | -17.4% | +45.9% |
| EBITDA CAGR (3Y) | +6.1% | - | - | - | +491.0% | - | +115.4% |
| Profitability & leverage | |||||||
| Net income margin | +1.5% | +2.4% | +1.0% | +1.1% | +1.2% | +3.5% | +1.5% |
| Return on capital employed | - | +0.3% | +0.5% | +2.5% | +1.5% | +3.1% | +1.3% |
| Return on net worth | - | +1.3% | +0.9% | +1.2% | +1.8% | +5.0% | +2.3% |
| Debt / equity | - | 6.76 | 4.53 | 0.09 | 0.10 | 0.08 | 0.08 |
| Long-term debt / equity | - | 6.67 | 4.44 | 0.00 | 0.01 | 0.04 | 0.08 |
| Interest cover | 0.45 | 32.03 | 284.21 | 4.57 | -0.01 | -3.18 | -1.64 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 7.21 | 10.68 | 14.70 | 21.76 | 28.71 | 49.73 |
| Inventory turnover | - | 36.07 | 41.40 | 32.48 | 54.54 | 137.26 | 146.42 |
| Debtors turnover | - | 1.50 | 2.99 | 2.48 | 1.87 | 1.60 | 2.29 |
| EPS (₹) | 0.01 | 0.02 | 0.01 | 0.03 | 0.21 | 0.56 | 0.25 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 1.73 | 1.26 | 2.37 | 11.71 | 11.51 | 10.95 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 23.83 | 29.66 | 35.18 | 24.60 | 25.03 | 20.66 | 15.18 | 21.58 |
| Revenue growth (YoY) | -4.8% | +43.6% | +131.8% | +14.0% | -6.3% | +1.2% | - | - |
| Other income | 0.80 | 0.02 | 0.55 | 0.26 | 0.34 | 0.00 | 0.03 | 0.10 |
| Total expenses | 23.92 | 29.01 | 34.85 | 24.19 | 24.82 | 19.74 | 15.10 | 21.31 |
| EBITDA | (0.09) | 0.65 | 0.33 | 0.41 | 0.21 | 0.92 | 0.08 | 0.27 |
| EBITDA margin | -0.4% | +2.2% | +0.9% | +1.7% | +0.8% | +4.5% | +0.5% | +1.3% |
| Depreciation | 0.19 | 0.11 | 0.31 | 0.12 | 0.12 | 0.12 | 0.16 | 0.11 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.31 | 0.00 |
| Profit before tax | 0.52 | 0.56 | 0.57 | 0.55 | 0.43 | 0.79 | (0.36) | 0.26 |
| Tax | 0.13 | 0.15 | 0.10 | 0.14 | 0.11 | 0.21 | 0.14 | 0.07 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 105 | 83.89 | 54.90 | 68.73 | 71.63 | 50.68 | 97.42 |
| Revenue growth | +25.7% | +52.8% | -20.1% | -4.1% | +41.3% | -48.0% | - |
| Other income | 0.89 | 0.14 | 0.87 | 1.86 | 0.04 | 74.40 | 11.40 |
| Total expenses | 104 | 81.94 | 53.34 | 67.17 | 69.28 | 123 | 103 |
| Employee cost | 0.00 | 0.31 | 0.54 | 0.68 | 0.12 | 0.09 | 0.04 |
| EBITDA | 1.83 | 1.95 | 1.56 | 1.56 | 2.35 | (72.29) | (5.98) |
| EBITDA margin | +1.7% | +2.3% | +2.8% | +2.3% | +3.3% | -142.6% | -6.1% |
| Depreciation | 0.66 | 0.47 | 0.42 | 0.39 | 0.21 | 0.24 | 0.31 |
| Interest | 0.01 | 0.41 | 0.49 | 0.18 | 0.10 | 0.01 | 0.20 |
| Profit before tax | 2.05 | 1.21 | 1.52 | 2.85 | 2.08 | 1.86 | 4.91 |
| Tax | 0.53 | 0.48 | 0.36 | 0.86 | 1.28 | 0.60 | 1.42 |
| Net profit | 1.52 | 0.73 | 1.16 | 1.99 | 0.80 | 1.29 | 3.49 |
| Net profit margin | +1.4% | +0.9% | +2.1% | +2.9% | +1.1% | +2.6% | +3.6% |
| EPS (₹) | 0.01 | 0.00 | 0.02 | 0.03 | 0.03 | 0.20 | 0.56 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 188 | 188 | 70.80 | 66.44 | 61.93 | 61.93 | 61.93 |
| Reserves & surplus | 227 | 225 | 34.11 | 24.91 | 18.42 | 17.59 | 16.36 |
| Shareholders' funds (net worth) | 436 | 435 | 105 | 91.35 | 80.35 | 79.52 | 78.29 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 376 | 374 | 683 | 695 | 5.65 | 6.70 | 5.83 |
| Total debt | 376 | 374 | 683 | 695 | 5.65 | 6.70 | 5.83 |
| Total liabilities | 812 | 809 | 788 | 800 | 101 | 96.24 | 168 |
| Assets | |||||||
| Gross block | 15.07 | 15.14 | 14.87 | 14.77 | 12.36 | 12.01 | 11.89 |
| Net block | 9.79 | 10.52 | 10.72 | 10.98 | 8.96 | 8.84 | 8.94 |
| Capital work in progress | 0.29 | 0.00 | 0.00 | 0.00 | 2.13 | 0.00 | 0.00 |
| Investments | 711 | 709 | 699 | 699 | 0.92 | 0.93 | 0.07 |
| Inventories | 1.67 | 2.08 | 0.47 | 1.11 | 0.38 | 0.06 | 0.56 |
| Sundry debtors | 82.74 | 87.46 | 88.27 | 28.49 | 11.83 | 45.45 | 68.01 |
| Cash & bank balances | 0.09 | 0.03 | 0.39 | 0.07 | 1.13 | 0.36 | 0.22 |
| Loans & advances | 10.40 | 4.84 | 3.74 | 51.75 | 54.10 | 59.77 | 58.42 |
| Total current assets | 94.90 | 94.41 | 92.87 | 81.42 | 67.44 | 106 | 127 |
| Total current liabilities | 56.24 | 55.27 | 60.39 | 35.32 | 24.15 | 42.49 | 55.01 |
| Net working capital | 38.66 | 39.14 | 32.48 | 46.10 | 43.29 | 63.15 | 72.20 |
| Total assets | 812 | 809 | 788 | 800 | 101 | 96.24 | 168 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.03 | 0.39 | 0.07 | 1.13 | 0.36 | 0.22 | 0.34 |
| Net cash from operating activities | (22.88) | (5.93) | (2.18) | (2.53) | (4.88) | 3.96 | (1.67) |
| Net cash from investing activities | 21.92 | (14.51) | 2.22 | (697) | 5.68 | (4.71) | 1.92 |
| Net cash from financing activities | 1.02 | 20.08 | 0.27 | 699 | (0.03) | 0.88 | (0.37) |
| Net change in cash | 0.06 | (0.36) | 0.32 | (1.05) | 0.77 | 0.13 | (0.11) |
| Closing cash | 0.09 | 0.03 | 0.39 | 0.07 | 1.13 | 0.36 | 0.22 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +25.7% | +52.8% | -20.1% | -4.1% | +41.3% | -48.0% | - |
| EBITDA growth | -6.2% | +25.0% | 0.0% | -33.6% | +103.3% | -1108.9% | - |
| PBT growth | +69.4% | -20.4% | -46.7% | +37.0% | +11.8% | -62.1% | +123.2% |
| Net income growth | +108.2% | -37.1% | -41.7% | +148.8% | -38.0% | -63.0% | - |
| Revenue CAGR (3Y) | +15.3% | +5.4% | +2.7% | -11.0% | -8.0% | -9.2% | -18.1% |
| EBITDA CAGR (3Y) | +5.5% | -6.0% | - | - | - | +456.3% | - |
| Profitability & leverage | |||||||
| Net income margin | +1.4% | +0.9% | +2.1% | +2.9% | +1.1% | +2.5% | +3.6% |
| Return on capital employed | - | +0.2% | +0.3% | +0.7% | +2.4% | +1.5% | +3.1% |
| Return on net worth | - | +0.3% | +1.3% | +2.5% | +1.1% | +1.7% | +5.0% |
| Debt / equity | - | 2.01 | 7.56 | 4.44 | 0.08 | 0.09 | 0.08 |
| Long-term debt / equity | - | 2.01 | 7.53 | 4.37 | 0.00 | 0.00 | 0.03 |
| Interest cover | 0.85 | 27.70 | 42.98 | 15.38 | 4.67 | -0.01 | -3.18 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 10.55 | 7.07 | 10.55 | 13.95 | 10.34 | 21.51 |
| Inventory turnover | - | 65.80 | 69.49 | 92.26 | 325.59 | 163.48 | 178.75 |
| Debtors turnover | - | 0.95 | 0.94 | 3.41 | 2.50 | 0.89 | 1.59 |
| EPS (₹) | 0.01 | 0.00 | 0.02 | 0.03 | 0.03 | 0.20 | 0.56 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 2.16 | 1.38 | 1.27 | 2.37 | 11.70 | 11.50 |
To see the full year-wise statements and ratios of Evexia Lifecare Limited, buy the company report.
Board of directors of Evexia Lifecare Limited
Evexia Lifecare has 6 current directors and 31 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hasmukhbhai Dhanjibhai Thakkar Also directs: EV Nest Private Limited | Director | 01 Jul 2018 | 8 Years 4 Months | Current |
| Kartik Kumar Bakulchandra Mistry Also directs: Kavit Cables Private Limited | Director | 06 Sep 2017 | 9 Years 2 Months | Current |
| Jayeshkumar Raichandbhai Thakkar Also directs: Mercury Ev-Tech Limited, Kavit Edible Oil Limited, Dc2 Mercury Cars Private Limited and 5 more | Managing Director | 28 Jan 2011 | 15 Years 9 Months | Current |
| Krupalibahen Rajeshbhai Mehta | Director | 30 May 2025 | 1 Years 5 Months | Current |
| Parth Vijaybhai Patel | Director | 09 Nov 2023 | 3 Years 0 Months | Current |
| Mohammadraza Makrani | Director | 09 Nov 2023 | 3 Years 0 Months | Current |
Peer comparison
Evexia Lifecare Limited is compared with the 3 companies closest to it by revenue in the Agriculture industry (Agro Retail and Distribution, Chemical Retail and Distribution, Edible Oils), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Evexia Lifecare Limitedthis company | ₹110.28 Cr (FY 2026) | ₹1.62 Cr | 1.5% | Vadodara, Gujarat, India | ||
| Brijmohan Azad Singh Marketing Private Limited | ₹57.2 Cr (FY 2025) | 15.0% | Madhya Pradesh, India | |||
| Ajinkya Marine Private Limited | ₹57.14 Cr (FY 2025) | 27.0% | Ratnagiri, Maharashtra, India | |||
| Barbarik Venture (India) Private Limited | ₹57.08 Cr (FY 2024) | 265.0% | Raipur, Chhattisgarh, India |
To see the full peer comparison of Evexia Lifecare Limited, buy the company report.
Auditor
Evexia Lifecare Limited is audited by M SAHU & COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M SAHU & COMPANY | FY 2023 | 130001W |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 3.40%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.10% and retail and other public shareholders hold 96.50%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 3.40% | 3.40% | 3.50% | 3.40% |
| Public | 96.60% | 96.60% | 96.50% | 96.60% |
Deals & funding
Evexia Lifecare Limited has 41 deals on record (40 market trades, 1 funding round), with disclosed funding of ₹24 Cr; the latest was in September 2026.
Deals on record (5 of 41)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2026 | Market trade | ₹1.67 Cr | Buyer: Mansi Share and Stock Broking Private Limited Seller: Mansi Share and Stock Broking Private Limited |
| Sep 2026 | Market trade | ₹7.96 Cr | Buyer: Shree Saibaba Exim Private Limited , Mansi Share and Stock Broking Private Limited , F3 Advisors Private Limited Seller: Prijal Tradefin LLP , F3 Advisors Private Limited |
| Sep 2026 | Market trade | ₹2.18 Cr | Buyer: Shree Saibaba Exim Private Limited |
| Sep 2026 | Market trade | ₹5.51 Cr | Buyer: Shree Saibaba Exim Private Limited |
| Sep 2026 | Market trade | ₹5.08 Cr | Buyer: Setu Securities Private Limited , Neo Apex Share Broking Services LLP Seller: Nishchaya Tradings Private Limited , Neo Apex Share Broking Services LLP |
To see the full deal history of Evexia Lifecare Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Evexia Lifecare Limited has 19 court cases on record: 9 filed by Evexia Lifecare, 10 filed against it. 9 cases are pending and 10 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 12 | 9 | 8 |
| District courts | 6 | 1 | 0 |
| Supreme Court | 1 | 0 | 1 |
Cases on record (5 of 19)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (1803-Ordinary Civil Matters : Civil matters arising out of Securities Act, 1992) | Filed by the company against Oasis Nutraceuticals Ltd. (Formerly Sam Leasco Ltd.) THR Is Manager THR Is Manager H-4-5 Everest Building, 9Th Floor Tardeo Road ,Mumbai , Maharashtra and 8 others | Pending |
| Bombay High Court | Court case (SPRP) | Filed by the company against Sage Consultants Pvt Ltd and 3 others | Disposed |
| High Court of Gujarat | Court case (TAXAP) | Filed by the company against Income Tax Officer Ward-1(1)(1) | Pending |
| High Court, GUJARAT | Court case (TAXAP) | Filed against the company by The Principal Commissioner of Income Tax, Vadodara 1 | Pending |
| High Court, GUJARAT | Court case (TAXAP) | Filed against the company by The Principal Commissioner of Income-Tax, Vadodara 1 | Pending |
To see the full case history of Evexia Lifecare Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Evexia Lifecare Limited was last rated by Crisil on 15 Dec 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 15 Dec 2020 |
To see the full credit ratings and regulatory alerts of Evexia Lifecare Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Evexia Lifecare Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Evexia Lifecare has 4 subsidiary companies. This group structure data is as of FY 2019. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Kavit Edible Oil Limited | U15100GJ2017PLC096076 | |
| Kavit Swachh Organic Food Private Limited | U15490GJ2016PTC094300 | |
| Kavit Infra Project Private Limited | U45209GJ2015PTC083192 | |
| Kavit Trading Private Limited | U74110GJ2016PTC086091 |
To see the full group structure of Evexia Lifecare Limited, buy the company report.
GST
Evexia Lifecare has 5 GST registrations: 4 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACJ4907C1Z3 | Gujarat | Active | 01 Jul 2017 |
| 24AAACJ4907C2Z2 | Gujarat | Active | 01 Jun 2023 |
| 27AAACJ4907C1ZX | Maharashtra | Active | 09 Mar 2018 |
| 36AAACJ4907C1ZY | Telangana | Active | 01 Sep 2021 |
To see the full GST registrations and return filing status of Evexia Lifecare Limited, buy the company report.
Recent activity
Evexia Lifecare Limited has 57 board changes on record since 2000: 32 appointments and 25 cessations. The latest: Krupalibahen Rajeshbhai Mehta was appointed as Director on 30 May 2025.
48 earlier events are in the company report.
News
Frequently asked questions
Evexia Lifecare is an active public limited company based in Vadodara, Gujarat, India. The company works in agro retail and distribution, within the agriculture industry. It was incorporated on 23 November 1990 (36+ years old) and is registered under CIN L23100GJ1990PLC014692. Listed on BSE: 524444.
Evexia Lifecare reported revenue of ₹110.28 Cr for FY 2025-26 based on consolidated financials.
Evexia Lifecare has 6 current directors:
- Jayeshkumar Raichandbhai Thakkar - Managing Director
- Hasmukhbhai Dhanjibhai Thakkar - Director
- Kartik Kumar Bakulchandra Mistry - Director
- Krupalibahen Rajeshbhai Mehta - Director
- Parth Vijaybhai Patel - Director
- Mohammadraza Makrani - Director
The latest financial statements of Evexia Lifecare on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 November 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Evexia Lifecare is 24AAACJ4907C1Z3, registered in Gujarat. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 24AAACJ4907C2Z2 (Gujarat), 27AAACJ4907C1ZX (Maharashtra), 36AAACJ4907C1ZY (Telangana).
The CIN (Corporate Identification Number) of Evexia Lifecare is L23100GJ1990PLC014692. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Evexia Lifecare is a listed company as per MCA records. Its shares are listed on BSE (code: 524444).
Evexia Lifecare has 19 court cases on record: 9 filed by the company and 10 filed against it. 9 are pending. Most are in the high courts.
Evexia Lifecare was incorporated on 23 November 1990, making it 36+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Evexia Lifecare has 41 deals on record (40 market trades, 1 funding round), with disclosed funding of ₹24 Cr; the latest was in September 2026.
The peers of Evexia Lifecare by revenue are Brijmohan Azad Singh Marketing Private Limited, Ajinkya Marine Private Limited, Barbarik Venture (India) Private Limited, all in the Agriculture industry (Agro Retail and Distribution, Chemical Retail and Distribution, Edible Oils), with the same principal business activity (wholesale trading).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
